Astrana Health, Inc. (ticker: ASTH) is an NASDAQ-listed services-management consulting services company. DredgeCap's structured extraction of ASTH's SEC filings surfaces 23 active risk signals, including 22 late-filing signals, and 1 auditor-change signal. ASTH reported $965.10M in revenue and $14.44M for the period ending 2026-03-31, with operating cash flow of $68.06M. Cash and equivalents stood at $478.38M (up 85% year-over-year). Total assets of $2.36B exceed total liabilities of $1.78B. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ASTH SEC Filings
Full cached SEC EDGAR filing history for ASTH, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.